Know Cancer

or
forgot password
  • cancer clinical trials in baltimore, MD

  • Multimodality Phase II Study in Prostate Cancer
    Johns Hopkins University
    Baltimore, Maryland 21205
    Prostate Cancer
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    Sinai Hospital of Baltimore
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    An Efficacy Study of MORAb-009 Amatuximab in Subjects With Pleural Mesothelioma
    Johns Hopkins University--Sidney Kimmel Comprehensive Cancer Center
    Baltimore, Maryland 21201
    Malignant Pleural Mesothelioma
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Greater Baltimore Medical Center
    Baltimore, Maryland 21204
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Phase II Study of Oral Panobinostat in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma
    VA Maryland Health Care Dept.of GreenbaumCancerCent(5)
    Baltimore, Maryland 21201
    Classical Hodgkin's Lymphoma (i.e. Nodular Sclerosing, Mixed-cellularity, Lymphocyte-rich, Lymphocyte-depleted)
    Lymphoma Follow-up
    NIA Clinical Research Unit
    Baltimore, Maryland 21225
    Lymphoma
    CryoSpray Ablation (TM) GI Patient Registry
    University of Maryland Medical Center
    Baltimore, Maryland 21201-1595
    Barrett's Esophagus With or Without Dysplasia, Squamous Dysplasia of the Esophagus, Esophageal Cancer (Any Stage)
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Greenebaum Cancer Center at University of Maryland Medical Center
    Baltimore, Maryland 21201
    Lung Cancer
    A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Baltimore, Maryland 21231
    Osteosarcoma
    Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
    University of Maryland Greenebaum Cancer Center
    Baltimore, Maryland 21201
    Lung Cancer, Non Small Cell Lung Cancer
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    Johns Hopkins University
    Baltimore, Maryland 21205
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Baltimore, Maryland 21215
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
    Research Site
    Baltimore, Maryland
    Recurrent Glioblastoma
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Sinai Hospital of Baltimore

    Trial Locations
    Sinai Hospital of Baltimore
    Greater Baltimore Medical Center
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    University of Maryland Greenebaum Cancer Center
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231
    MDS, Leukemias, Lymphomas
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Sinai Hospital of Baltimore

    Trial Locations
    Sinai Hospital of Baltimore
    Franklin Square Hospital Center
    Greater Baltimore Medical Center
    University of Maryland Greenebaum Cancer Center
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center

    Trial Locations
    Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Greenebaum Cancer Center at University of Maryland Medical Center
    Greater Baltimore Medical Center Cancer Center
    St. Agnes Hospital Cancer Center
    Endometrial Cancer, Fatigue, Neurotoxicity
    Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Trial Locations
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Greenebaum Cancer Center at University of Maryland Medical Center
    Greater Baltimore Medical Center Cancer Center
    Lymphoma
    Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    Sinai Hospital of Baltimore
    Baltimore, Maryland 21225
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Cytokine Expression During Radiation for Breast Cancer
    The Johns Hopkins University School of Medicne
    Baltimore, Maryland 21231
    Breast Cancer
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    Sidney Kimmel Comphrensive Cancer Center, John Hopkins University
    Baltimore, Maryland 21231
    Metastatic Pancreatic Cancer
    Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma
    The Johns Hopkins Hospital
    Baltimore, Maryland 21205
    Hepatocellular Carcinoma, Hepatoma
    A Study of of MORAb-004 in Subjects With Solid Tumors
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Baltimore, Maryland 21231
    Solid Tumor
    Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Breast Cancer
    Evaluating the Safety and Effectiveness of a Bone Marrow Transplant From Partially Matched Donors and Using Low Dose Chemotherapy in People With Leukemia or Lymphoma (BMT CTN #0603)
    University of Maryland, Greenbaum Cancer Center

    Trial Locations
    University of Maryland, Greenbaum Cancer Center
    Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center (SKCCC)
    Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    John Hopkins University

    Trial Locations
    John Hopkins University
    Weinberg Cancer Institute at Franklin Square
    Ovarian Cancer
    OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    Greater Baltimore Medical Center
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
    University of Maryland Greenebaum Cancer Center
    Baltimore, Maryland 21201
    High-grade Salivary Gland Mucoepidermoid Carcinoma, Low-grade Salivary Gland Mucoepidermoid Carcinoma, Recurrent Salivary Gland Cancer, Salivary Gland Acinic Cell Tumor, Salivary Gland Adenocarcinoma, Salivary Gland Adenoid Cystic Carcinoma, Salivary Gland Anaplastic Carcinoma, Salivary Gland Malignant Mixed Cell Type Tumor, Salivary Gland Poorly Differentiated Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    The Bunting-Blaustein Cancer Research Building
    Baltimore, Maryland 21231
    Prostate Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Franklin Square Hospital Center

    Trial Locations
    Franklin Square Hospital Center
    Greater Baltimore Medical Center
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer